Kravchenko, A. V., Orlova-Morozova, E. A., Shimonova, T. E., Kozyrev, O. A., Nagimova, F. I., Zaharova, N. G., . . . Vostokova, N. V. (2018). Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study. Journal Infectology.
Chicago Style (17th ed.) CitationKravchenko, A. V., et al. Efficacy and Safety of Novel Russian Non-nucleoside Reverse Transcriptase Inhibitor Elsulfavirine in Combination with 2 Nucleoside/nucleotide Reverse Transcriptase Inhibitors in First-line HIV Treatment – 96-week Study. Journal Infectology, 2018.
MLA (9th ed.) CitationKravchenko, A. V., et al. Efficacy and Safety of Novel Russian Non-nucleoside Reverse Transcriptase Inhibitor Elsulfavirine in Combination with 2 Nucleoside/nucleotide Reverse Transcriptase Inhibitors in First-line HIV Treatment – 96-week Study. Journal Infectology, 2018.